FEB 03, 2019 1:28 PM PST

Hyperactive Neurons May Interfere with the Efficacy of Antidepressants

WRITTEN BY: Carmen Leitch

Depression impacts over 300 million people worldwide, and and it’s thought that about 6.7 percent of Americans experienced a major depressive episode in 2016. Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressant, but they don’t work for about a third of the people that take them. Salk Institute researchers have found a potential explanation for that; in some people, SSRIs cause neurons to become hyperactive. The findings have been reported in Molecular Psychiatry.

Image credit: Pxhere

"This is a promising step toward understanding why some patients don't respond to SSRIs and letting us better personalize treatments for depression," said the senior author of the study, Salk Professor Rusty Gage, president of the Institute, and the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Disease.

Major depressive disorder (MDD) has been connected to problems with a signaling chemical in the brain - a neurotransmitter called serotonin. A neuron releases serotonin, which can then bind to receptors on nearby neurons. SSRIs raise the amount of serotonin that’s available for binding; the drug blocks a transporting molecule that carries serotonin back inside the cells and away from the receptors - stopping reuptake.

Scientists at Salk and the Mayo Clinic looked at how 803 patients with MDD responded to SSRIs. Three patients that were successfully treated for depressive symptoms with SSRIs were selected, along with three that had not seen any improvement in symptoms after eight weeks of SSRI treatment. The researchers used skin cells from these patients to first create pluripotent stem cells and then neurons.

"What's exciting is that we could look directly at human cells, neurons that are not usually accessible in living patients," explained the first author of the report Krishna Vadodaria, a Salk staff scientist. "We can finally tap into the potential of looking at neurons from individuals whose medication histories, genetics and response profiles we know."

The team was able to explore how SSRIs impacted these neurons by exposing them to varying levels of serotonin. Neurons from patients that did not respond to SSRIs had a significantly higher average activity when serotonin was present compared to neurons from SSRI responders or healthy people.

Two serotonin receptors were implicated by additional studies, 5-HT2A and 5-HT7. After blocking these receptors with a chemical, the hyperactivity in the neurons from SSRI non-responders was reduced. Those receptors may, therefore, be a good therapeutic target for depression patients that don’t respond to SSRIs.

"I hope this opens the door to many more studies of individuals who are extreme cases in terms of how they respond to treatments," said Vadodaria. "In turn, that will help us understand major depression in the broader population."

The video above from the Atlantic and by visual artists Emma Allen and clinical neuroscientist Dr. Daisy Thompson-Lake explores the neuroscience of depression with an artistic flare.


Sources: AAAS/Eurekalert! Via Salk Institute, WHONIMH, Molecular Psychiatry, Conscioused

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 06, 2022
Chemistry & Physics
2022 Nobel Prize in Chemistry
OCT 06, 2022
2022 Nobel Prize in Chemistry
It’s that time of year again! Three scientists, Carolyn R. Bertozzi, Morten Meldal, and K. Barry Sharpless, were a ...
NOV 06, 2022
Genetics & Genomics
The Lone Participant in a CRISPR Therapy Trial has Died
NOV 06, 2022
The Lone Participant in a CRISPR Therapy Trial has Died
In August of this year, a single patient was enrolled in a trial that used CRISPR to correct a genetic mutation that led ...
NOV 17, 2022
Cannabis Sciences
What It Means If You Are Ediblocked
NOV 17, 2022
What It Means If You Are Ediblocked
What ediblocking is, and how it affects you
NOV 18, 2022
Cell & Molecular Biology
Mitochondria Can Signal to the Immune & Nervous Systems
NOV 18, 2022
Mitochondria Can Signal to the Immune & Nervous Systems
Mitochondria are little organelles that have long been known as the powerhouses of the cell. But in recent years, scient ...
NOV 25, 2022
Drug Discovery & Development
Antibiotics for Acne May Impair Bone Development in Teens
NOV 25, 2022
Antibiotics for Acne May Impair Bone Development in Teens
Long-term antibiotic use to treat adolescent acne disrupts the gut microbiome and impairs bone maturation. The correspon ...
NOV 29, 2022
Genetics & Genomics
Eliminating 'Toxic' RNA Molecules to Treat ALS & Dementia
NOV 29, 2022
Eliminating 'Toxic' RNA Molecules to Treat ALS & Dementia
Researchers have developed a way to target RNA molecules that can have a harmful result. Instead of targeting the genome ...
Loading Comments...